Dejan Juric

机构：Harvard University, Massachusetts General Hospital, Dana-Farber/Harvard Cancer Center, Global Cancer Institute, Center for Cancer Research, Mass General Brigham · ORCID：0000-0003-2983-7704

发表论文 734 篇 · 总被引 22066 次 · h-index 62

代表论文

• Acquired On-Target Alterations Drive Clinical Resistance to p53-Y220C Reactivators (2026 · Cancer Discovery · 被引 6)
• Coping Strategies Among Early-Phase Cancer Clinical Trial Participants (2026 · Journal of the National Comprehensive Cancer Network)
• Actionable genetic landscape and dynamics in circulating DNA from 12,827 patients with metastatic breast cancer (2026 · Nature Communications)
• Genomic biomarkers of ipatasertib response in patients with hormone receptor-positive metastatic breast cancer (2026 · npj Breast Cancer)
• Tumor-directed therapy in HR+ Breast Cancer oligoprogression to mutant selective PI3K-alpha inhibitor plus fulvestrant (2026 · npj Breast Cancer)
• CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor–Resistant HR+/HER2− Breast Cancer (2026 · Cancer Research)